Piramal Pharma Solutions Inc. today announced plans to expand its current Lexington operations with a nearly $80 million ...

Piramal Pharma Solutions (PPS), the global contract manufacturing division of Piramal Pharma Ltd, is set to invest $80 ...

As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of ...

Piramal Pharma Solutions invests $80 million in Lexington facility expansion to meet growing demand in injectables market.

The expansion will equip the Lexington site with an additional 24,000 square feet of manufacturing space, a new lab, and ...

The investment has been financed through bank loans and internal accruals, and aims to enhance site’s capacity to meet rising ...

Stocks including NTPC, Tata Power, IRCTC, Blue Dart, Andhra Cements, Bank of Maharashtra, Piramal Pharma and more will be the ...

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Organization (CDMO) and part of Piramal Pharma has unveiled an $80M investment plan to expand its Lexington, ...

Mumbai: Piramal Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA ...

Piramal Pharma, chaired by Nandini Piramal, aims to become a global pharma and wellness giant exceeding $2 billion by FY30.

Tata Consumer Products, Indian Railway Catering and Tourism Corporation, Andhra Cements, Zuari Industries, India Glycols, ...